-
Study aim
-
determining the effect of using dexmedetomidine in inducing and maintaining anesthesia in cardiac surgery
comparing the hemodynamic responses, the incidence of arrhythmia, and the inflammatory factors after operation between groups
comparing the post-operative recovery time, the lactate level, blood sugar level, and side effects of the drugs between groups
comparing the effects of dexmedetomidine on cardiovascular stress responses during and after open heart surgery
-
Design
-
This is a single-center randomized controlled trial (third phase), with balanced randomization [1:1]), double-blind (patients, and investigator), and parallel-group study. 70 patients will be allocated into two groups (35 patients in each). For randomization, sealedenvelope.com online site will use.
-
Settings and conduct
-
The study will be performed in the Sayyad Shirazi Hospital in Gorgan. The vital signs and the lactate level will be recorded before, during, and after the induction of the drug.
The inflammatory factors will be measured before and ۲۴ hours after surgery.
-
Participants/Inclusion and exclusion criteria
-
Inclusion:
aged between 18-65 years both sexes
Patients under one of these surgery (pump coronary artery bypass, valvular replacement or valvular repair)
Informed consent to participate in the study
Exclusion:
Patients with underlying diseases (serious coagulopathy, inflammation, ...)
Patients use these medicines (steroids, anti-inflammatory drugs, immunosuppressive)
-
Intervention groups
-
Pretreatment drugs and induction of anesthesia will be the same for all patients.
Intervention for maintenance of anesthesia:
In Dexmedetomidine group: ۰.۵ mcg/kg/hr of dexmedetomidine infusion, midazolam ۰.۱ – ۰.۲ mg/kg/hr
In controlled group: isoflurane ۰.۴% as inhalational agent, midazolam ۰.۱ – ۰.۲ mg/kg/hr
-
Main outcome variables
-
hemodynamic responses
inflammatory factors, lactate level and post-operative recovery time